Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies
Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies
复制标题
与来自成熟 B 细胞恶性肿瘤患者的 CAR T 细胞相比，来自健康捐赠者的同种异体抗 CD19 CAR T 细胞提供了具有独特表型特征的独特细胞产品
DOI：
10.1182/blood-2019-123018
复制
发表时间：
2019
期刊：
影响因子：
20.3
通讯作者：
Graham C
中科院分区：
文献类型：
--
作者：
Graham C
